Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma.

Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma.

Lymphoma-specific biomarkers contribute to therapeutic strategies and the study of tumorigenesis. Diffuse large B-cell lymphoma (DLBCL) is the most common type of malignant lymphoma. However, only 50% of patients experience long-term survival after current treatment; therefore, developing novel ther...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kung-Chao Chang, Wei-Chao Chang, Yao Chang, Liang-Yi Hung, Chien-Hsien Lai, Yu-Min Yeh, Yu-Wei Chou, Chung-Hsuan Chen
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/132c1591d29a4d2797e33f88ef9fba88
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares